These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32983577)

  • 1. Preclinical optimization of an enterotoxigenic
    Poncet D; Hessler C; Liang H; Gautheron S; Sergent M; Rintala ND; Seydoux E; Huang PD; Argilla D; Ruiz S; Heinrichs J; Maciel M; Orr MT
    NPJ Vaccines; 2020; 5():83. PubMed ID: 32983577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
    Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant effect of enterotoxigenic
    Seo H; Lu T; Mani S; Bourgeois AL; Walker R; Sack DA; Zhang W
    Hum Vaccin Immunother; 2020; 16(2):419-425. PubMed ID: 31361177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine.
    Liang H; Poncet D; Seydoux E; Rintala ND; Maciel M; Ruiz S; Orr MT
    NPJ Vaccines; 2019; 4():19. PubMed ID: 31149350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.
    Ruan X; Sack DA; Zhang W
    PLoS One; 2015; 10(3):e0121623. PubMed ID: 25803825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
    Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
    Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens.
    Zhou S; Yu KOA; Mabrouk MT; Jahagirdar D; Huang WC; Guerra JA; He X; Ortega J; Poole ST; Hall ER; Gomez-Duarte OG; Maciel M; Lovell JF
    Biomed J; 2023 Dec; 46(6):100588. PubMed ID: 36925108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
    Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J
    Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
    Svennerholm AM
    Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
    Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
    Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
    Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
    Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
    Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
    Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM
    Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.